Peter Chang
Impact in
- Pathology and Forensic Medicine top 0.5%
- Multiple Sclerosis Research Studies
- Rheumatology top 1%
- Systemic Lupus Erythematosus Research
Papers in
-
- Prostate Cancer Diagnosis and Treatment 36
- Renal cell carcinoma treatment 27
- Prostate Cancer Treatment and Research 26
- Surgery 46
- Bladder and Urothelial Cancer Treatments 22
- Co-authors
- Andrew A. Wagner (55 shared papers)Peter Rieckmann (3 shared papers)Kottil Rammohan (2 shared papers)Anthony Hamlett (1 shared paper)Patrick Vermersch (2 shared papers)Steven J. Greenberg (1 shared paper)Gıancarlo Comı (1 shared paper)Per Soelberg Sørensen (2 shared papers)
- Journals
- The Journal of Urology (26 papers)Urologic Oncology Seminars and Original Investigations (11 papers)Urology (9 papers)Journal of Clinical Oncology (8 papers)Prostate Cancer and Prostatic Diseases (3 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Peter Chang
140 papers receiving 4.3k citations
Peter Chang's Hit Papers
Peers
Comparison fields: 5 of 133
- Pathology and Forensic Medicine 1.4k
- Rheumatology 731
- Pulmonary and Respiratory Medicine 1.4k
- Neurology 519
- Oncology 781
Countries citing papers authored by Peter Chang
This map shows the geographic impact of Peter Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Chang more than expected).
Fields of papers citing papers by Peter Chang
This network shows the impact of papers produced by Peter Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Chang. The network helps show where Peter Chang may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Chang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 151 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A Placebo-Controlled Trial of Oral Cladribine for Relapsing Multiple Sclerosis Hit paper breakdown → | 2010 | 689 |
| 2 | 2008 | 352 | |
| 3 | 2005 | 284 | |
| 4 | 2015 | 247 | |
| 5 | 2017 | 170 | |
| 6 | 2011 | 144 | |
| 7 | 2005 | 142 | |
| 8 | 2010 | 133 | |
| 9 | 1998 | 100 | |
| 10 | 1983 | 86 | |
| 11 | 2007 | 80 | |
| 12 | 2005 | 80 | |
| 13 | 2019 | 76 | |
| 14 | 2014 | 74 | |
| 15 | 2005 | 73 | |
| 16 | 2017 | 73 | |
| 17 | 2018 | 69 | |
| 18 | 2005 | 60 | |
| 19 | 2013 | 56 | |
| 20 | 2012 | 56 |
About Peter Chang
Peter Chang is a scholar working on Pulmonary and Respiratory Medicine, Surgery, Oncology, Molecular Biology and Rheumatology, having authored 151 papers that have together received 4.5k indexed citations. Recurring topics across this work include Prostate Cancer Diagnosis and Treatment (36 papers), Renal cell carcinoma treatment (27 papers), Prostate Cancer Treatment and Research (26 papers), Bladder and Urothelial Cancer Treatments (22 papers), Renal and related cancers (16 papers), Multiple Sclerosis Research Studies (12 papers), Health Systems, Economic Evaluations, Quality of Life (9 papers) and Urological Disorders and Treatments (8 papers). The work is most often cited by research in Pathology and Forensic Medicine (1.4k citations), Rheumatology (731 citations), Pulmonary and Respiratory Medicine (1.4k citations), Neurology (519 citations) and Oncology (781 citations). Peter Chang has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Andrew A. Wagner, Peter Rieckmann, Kottil Rammohan, Anthony Hamlett, Patrick Vermersch, Steven J. Greenberg, Gıancarlo Comı, Per Soelberg Sørensen, Gavin Giovannoni and Bruno Musch. Their work appears in journals such as The Journal of Urology, Urologic Oncology Seminars and Original Investigations, Urology, Journal of Clinical Oncology and Prostate Cancer and Prostatic Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.